Oncology

Over 70% of patients with early-stage breast cancer are diagnosed with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative…

There has been a decrease in the number of incidences of lung cancer recorded among men over the past few decades as well as among women…

Whoever you are, you have the power to reduce the impact of cancer for yourself, the people you love, and for the world. It’s time to make a personal…

A high-throughput artificial intelligence-powered image-based phenotyping platform, iBiopsy® (Median Technologies, Valbonne, France), which aims to…

Adding a molecular perspective to the traditional multidisciplinary management of cancer patients is substantially hampering the adoption of precision…

Adjuvant chemotherapy (CT) is commonly recommended to breast cancer patients following surgery. However, not all patients benefit from it, and the…

Cancer of unknown primary (CUP) accounts for 3–5% of all cancers, and prognosis is poor for most patients, with a median survival of 6–9 months…

This review presents the recent advances in our understanding of the cellular pathogenesis of T cell non-Hodgkin lymphoma (NHL) and the potential of…